Skip to main content

Advertisement

SpringerLink
Log in

Interaction of oxycodone and voriconazole—a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hagelberg NM, Nieminen TH, Saari TI, Neuvonen M, Neuvonen PJ, Laine K, Olkkola KT (2009) Voriconazole drastically increases exposure to oral oxycodone. Eur J Clin Pharmacol 65:263–271

    Article  PubMed  CAS  Google Scholar 

  2. Grönlund J, Saari TI, Hagelberg NM, Neuvonen PJ, Laine K, Olkkola KT (2010) Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and CYP3A pathways but not by inhibition of CYP2D6 alone. Br J Clin Pharmacol 70:78–87

    Article  PubMed  Google Scholar 

  3. Nieminen TH, Hagelberg NM, Saari TI, Neuvonen M, Neuvonen PJ, Laine K, Olkkola KT (2010) Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir. Eur J Clin Pharmacol 66:977–985

    Article  PubMed  CAS  Google Scholar 

  4. Nieminen TH, Hagelberg NM, Saari TI, Neuvonen M, Neuvonen PJ, Laine K, Olkkola KT (2010) Grapefruit juice enhances the exposure to oral oxycodone. Basic Clin Pharmacol Toxicol 107:782–788

    Article  PubMed  CAS  Google Scholar 

  5. Saari TI, Grönlund J, Hagelberg NM, Neuvonen M, Laine K, Neuvonen PJ, Olkkola KT (2010) Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone. Eur J Clin Pharmacol 66:387–397

    Article  PubMed  CAS  Google Scholar 

  6. Samer CF, Daali Y, Wagner M, Hopfgartner G, Eap CB, Rebsamen MC, Rossier MF, Hochstrasser D, Dayer P, Desmeules JA (2010) The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone. Br J Pharmacol 160:907–918

    Article  PubMed  CAS  Google Scholar 

  7. Kummer O, Hammann F, Moser C, Schaller O, Drewe J, Krähenbühl S (2010) Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. Eur J Clin Pharmacol. doi:10.1007/s00228-010-0893-3

    PubMed  Google Scholar 

  8. Samer CF, Daali Y, Wagner M, Hopfgartner G, Eap CB, Rebsamen MC, Rossier MF, Hochstrasser D, Dayer P, Desmeules JA (2010) Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety. Br J Pharmacol 160:919–930

    Article  PubMed  CAS  Google Scholar 

  9. Watanabe M, Homma M, Momo K, Okoshi Y, Wada T, Hara A, Chiba S, Kohda Y (2011) Effects of voriconazole co-administration on oxycodone-induced adverse effects—a case in the retrospective survey. Eur J Clin Pharmacol (in press)

Download references

Conflict of interest

Dr. Klaus T Olkkola has worked as a pharmacokinetic consultant for Akela Pharma Inc., Turku, Finland. Kari Laine is shareholder of Medbase Ltd. Other authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Anaesthesiology, Intensive Care, Emergency Care and Pain Medicine, University of Turku and Turku University Hospital, P.O. Box 52, 20521, Turku, Finland

    Nora M. Hagelberg, Tuija H. Nieminen, Teijo I. Saari & Klaus T. Olkkola

  2. Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

    Mikko Neuvonen & Pertti J. Neuvonen

  3. Department of Pharmacology, Drug Development & Therapeutics, University of Turku, Turku, Finland

    Kari Laine

Authors
  1. Nora M. Hagelberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tuija H. Nieminen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Teijo I. Saari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mikko Neuvonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pertti J. Neuvonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kari Laine
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Klaus T. Olkkola
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nora M. Hagelberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hagelberg, N.M., Nieminen, T.H., Saari, T.I. et al. Interaction of oxycodone and voriconazole—a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects. Eur J Clin Pharmacol 67, 863–864 (2011). https://doi.org/10.1007/s00228-010-0969-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-010-0969-0

Keywords

Search

Navigation